You are here

  • Home
  • Archive
  • Volume 72, Issue 2
  • Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic

Article metrics

Article menu
COVID-19
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic
Free

 

Online download statistics by month:

Online download statistics by month: July 2022 to March 2024

AbstractFullPdf
Jul 2022593613108
Aug 202220162021398
Sep 2022812809137
Oct 202233432969
Nov 202231730474
Dec 202232030559
Jan 2023703658237
Feb 2023262248109
Mar 2023196181101
Apr 202317916991
May 202321420581
Jun 202314314246
Jul 202314412372
Aug 202389788557
Sep 20231096108777
Oct 20231267125547
Nov 20231164113231
Dec 202384681929
Jan 202486984146
Feb 202476772939
Mar 202478077694
Total13919136312002